Your browser doesn't support javascript.
loading
The ability of eight frailty instruments to identify adverse outcomes across different settings: the FRAILTOOLS project.
Oviedo-Briones, Myriam; Rodríguez-Laso, Ángel; Carnicero, José Antonio; Gryglewska, Barbara; Sinclair, Alan J; Landi, Francesco; Vellas, Bruno; Rodríguez Artalejo, Fernando; Checa-López, Marta; Rodriguez-Mañas, Leocadio.
Afiliação
  • Oviedo-Briones M; Fundación para la Investigación Biomédica del Hospital Universitario de Getafe, Madrid, Spain.
  • Rodríguez-Laso Á; Facultad de Medicina, Universidad de las Américas, Quito, Ecuador.
  • Carnicero JA; CIBERFES: CIBER (Centers of the Network of Biomedical Research) thematic area of Frailty and Healthy Ageing, Instituto de Salud Carlos III, Madrid, Spain.
  • Gryglewska B; Fundación para la Investigación Biomédica del Hospital Universitario de Getafe, Madrid, Spain.
  • Sinclair AJ; Department of Internal Medicine and Gerontology, Jagiellonian University Medical Collegium Medicum, Cracow, Poland.
  • Landi F; Diabetes Frail and King's College, London, UK.
  • Vellas B; Hospital Centro Medicina dell'Invecchiamento, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Rodríguez Artalejo F; Gerontopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
  • Checa-López M; Preventive Medicine and Public Health School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
  • Rodriguez-Mañas L; Jefe de Servicio de Geriatría, Hospital Universitario de Getafe, Madrid, Spain.
J Cachexia Sarcopenia Muscle ; 13(3): 1487-1501, 2022 06.
Article em En | MEDLINE | ID: mdl-35429109
BACKGROUND: To compare the performance of eight frailty instruments to identify relevant adverse outcomes for older people across different settings over a 12 month follow-up. METHODS: Observational longitudinal prospective study of people aged 75 + years enrolled in different settings (acute geriatric wards, geriatric clinic, primary care clinics, and nursing homes) across five European cities. Frailty was assessed using the following: Frailty Phenotype, SHARE-FI, 5-item Frailty Trait Scale (FTS-5), 3-item FTS (FTS-3), FRAIL scale, 35-item Frailty Index (FI-35), Gérontopôle Frailty Screening Tool, and Clinical Frailty Scale. Adverse outcomes ascertained at follow-up were as follows: falls, hospitalization, increase in limitation in basic (BADL) and instrumental activities of daily living (IADL), and mortality. Sensitivity, specificity, and capacity to predict adverse outcomes in logistic regressions by each instrument above age, gender, and multimorbidity were calculated. RESULTS: A total of 996 individuals were followed (mean age 82.2 SD 5.5 years, 61.3% female). In geriatric wards, the FI-35 (69.1%) and the FTS-5 (67.9%) showed good sensitivity to predict death and good specificity to predict BADL worsening (70.3% and 69.8%, respectively). The FI-35 also showed good sensitivity to predict BADL worsening (74.6%). In nursing homes, the FI-35 and the FTSs predicted mortality and BADL worsening with a sensitivity > 73.9%. In geriatric clinic, the FI-35, the FTS-5, and the FRAIL scale obtained specificities > 85% to predict BADL worsening. No instrument achieved high enough sensitivity nor specificity in primary care. All the instruments predict the risk for all the outcomes in the whole sample after adjusting for age, gender, and multimorbidity. The associations of these instruments that remained significant by setting were for BADL worsening in geriatric wards [FI-35 OR = 5.94 (2.69-13.14), FTS-3 = 3.87 (1.76-8.48)], nursing homes [FI-35 = 4.88 (1.54-15.44), FTS-5 = 3.20 (1.61-6.38), FTS-3 = 2.31 (1.27-4.21), FRAIL scale = 1.91 (1.05-3.48)], and geriatric clinic [FRAIL scale = 4.48 (1.73-11.58), FI-35 = 3.30 (1.55-7.00)]; for IADL worsening in primary care [FTS-5 = 3.99 (1.14-13.89)] and geriatric clinic [FI-35 = 3.42 (1.56-7.49), FRAIL scale = 3.27 (1.21-8.86)]; for hospitalizations in primary care [FI-35 = 3.04 (1.25-7.39)]; and for falls in geriatric clinic [FI-35 = 2.21 (1.01-4.84)]. CONCLUSIONS: No single assessment instrument performs the best for all settings and outcomes. While in inpatients several commonly used frailty instruments showed good sensitivities (mainly for mortality and BADL worsening) but usually poor specificities, the contrary happened in geriatric clinic. None of the instruments showed a good performance in primary care. The FI-35 and the FTS-5 showed the best profile among the instruments assessed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragilidade Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragilidade Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article